This Master's degree in Cell and Gene Therapy provides an in-depth education in this cutting-edge and rapidly developing field. It is delivered by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation and DNA repair techniques.
Modes and duration
Tuition fees (2017/18)
- £11,800 (FT) N/A (PT)
- £25,890 (FT) N/A (PT)
Note on fees: The tuition fees shown are for the year indicated above. Fees for subsequent years may increase or otherwise vary. Further information on fee status, fee increases and the fee schedule can be viewed on the UCL Current Students website. Fees for flexible, modular study are charged pro-rata to the appropriate full-time Master's fee taken in an academic session.
Applicants should be: a qualified medical practitioner, with a qualification equivalent to a UK MBBS; a non-clinical scientist with a minimum of an upper second-class BSc or equivalent in a life or biomedical science subject; or a healthcare, pharmaceutical or biotech professional and scientist with equivalent experience (minimum of three years).
English language requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.
The English language level for this programme is: Standard
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
The degree covers all aspects of the subject, including basic biomedical science, molecular basis of disease, current and developing technologies and clinical applications. Students also receive vocational training in research methodology and statistics, how to perform a research project and complete a practical laboratory-based project.
Students undertake modules to the value of 180 credits.
The programme consists of four core modules (60 credits), four optional modules (60 credits) and a research dissertation (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months or flexible up to five years) is offered
A Postgraduate Certificate (60 credits, full-time 12 weeks, part-time nine months, or up to two years flexible) is offered.
- Molecular Aspects of Cell and Gene Therapy
- Clinical Applications of Cell and Gene Therapy
- Research Methodology and Statistics
- Stem Cell and Tissue Repair
Research Methodology and Statistics is not a core module for the PG Certificate. Students of the PG Certificate can choose an optional module.
- Foundations of Biomedical Sciences
- Applied Genomics
- HIV Frontiers from Research to Clinics
- Molecular and Genetic Basis of Paediatric Disease
- Understanding Research and Critical Appraisal: Biomedicine
- Laboratory Methods in Biomedical Science
- Research Methodology and Statistics
All MSc students undertake an independent research project which culminates in a dissertation.
Teaching and learning
Teaching includes lectures, seminars, problem classes and tutorials. Assessment varies depending on the module, but includes written coursework, multiple-choice questions, written examinations, a practical analysis examination and the dissertation.
For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
The majority of our graduates have gone on to secure PhD places. Please see our programme website to read testimonials from past students which include their destinations following graduation.
This novel programme aims to equip students for careers in research, education, medicine and business in academic, clinical and industrial settings. Examples of potential careers could include academic research and/or lecturing in a university or other higher education setting, conducting clinical trials as part of a team of clinicians, scientists and allied health professionals, monitoring and analysing the results of clinical trials as part of a clinical trials unit, developing new therapies or intellectual property in the pharmaceutical industry or other business ventures.
Why study this degree at UCL?
The Institute of Child Health (ICH), and its clinical partner Great Ormond Street Hospital (GOSH), is the largest centre in Europe devoted to clinical, basic research and post-graduate education in children's health, including haematopoietic stem cell transplantation (HSCT) and gene therapy.
The UCL School of Life & Medical Sciences (SLMS) has the largest concentration of clinicians and researchers active in cell and gene therapy research in Europe. This is reflected by the many groups conducting high-quality research and clinical trials in the field including researchers at the Institute of Child Health, the Division of Infection and Immunity, the Institute of Ophthalmology, the Institute for Women's Health, the Institute of Genetics and the Cancer Institute.
Department: Great Ormond Street Institute of Child Health
Student / staff numbers › 214 staff including 206 postdocs › 215 taught students › 170 research students
Research Excellence Framework (REF)
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Great Ormond Street Institute of Child Health
82% rated 4* (world-leading) or 3* (internationally excellent)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
What our students and staff say
"I came across the field of gene therapy while I was studying for my BSc in Biotechnology back home at Universitat Autònoma de Barcelona (UAB). After one year of part-time research experience on gene therapy for a rare metabolic disease, I felt I could develop my professional career in this field and decided to make it the main theme of my postgraduate education. This is the reason why I applied to UCL for my MSc studies. The UK is one of the leading countries in gene therapy, and UCL in particular is a world-ranked university that gathers a great number of the country’s leading academics in this technology. As a matter of fact, it is the only university in the UK providing a postgraduate education focusing specifically on cell and gene therapy. It is very exciting to know that by studying at UCL I got the chance to learn and interact with leading experts in the field."
Miguel Calero GarciaCell and Gene Therapy MSc
"I first moved to UCL in 2000 to do a PhD in Fetal Medicine and I have stayed ever since. The most attractive thing about UCL for me was the history of research and innovation within fetal medicine. This included major breakthroughs in treating fetal disease in the womb, such as fetal blood transfusion and shunts that are now performed routinely around the world. My main research is in translational medicine. I lead the Prenatal Cell and Gene Therapy Group at the UCL Institute for Women's Health. Our aim is to develop prenatal therapies for life-threatening disorders, for example congenital diseases such as thalassaemia, or obstetric complications such as fetal growth restriction. The best thing about working at UCL is the breadth of expertise in related medical and life sciences disciplines. Staff are always ready to discuss an idea and collaborate outside their field. "
Professor Anna David
Professor of Obstetrics and Maternal Fetal Medicine
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Who can apply?
The programme is designed for medical practitioners and scientists who would like to develop their knowledge in this distinct area, with a view to contributing to research and clinical trials in the field.
- All applicants
- 26 August 2017
For more information see our Applications page.Apply now
What are we looking for?
When we assess your application we would like to learn:
- why you want to study Cell and Gene Therapy at graduate level
- why you want to study Cell and Gene Therapy at UCL
- what particularly attracts you to this programme
- how your academic and professional background meets the demands of this challenging programme
- where you would like to go professionally with your degree
Together with essential academic requirements, the personal statement is your opportunity to illustrate whether your reasons for applying to this programme match what the programme will deliver.